S&P 500   3,971.35 (+0.01%)
DOW   32,375.05 (+0.43%)
QQQ   309.27 (-0.52%)
AAPL   159.21 (-0.65%)
MSFT   277.22 (-1.19%)
META   202.87 (-1.52%)
GOOGL   102.75 (-2.55%)
AMZN   97.54 (-0.60%)
TSLA   194.71 (+2.26%)
NVDA   266.33 (-0.55%)
NIO   8.88 (-2.09%)
BABA   85.58 (-1.52%)
AMD   96.22 (-1.77%)
T   18.88 (+1.45%)
F   11.50 (-0.09%)
MU   59.55 (-2.63%)
CGC   1.88 (-1.32%)
GE   93.08 (+1.87%)
DIS   94.63 (+0.58%)
AMC   4.32 (-3.36%)
PYPL   73.77 (-0.15%)
PFE   40.34 (-0.12%)
NFLX   329.75 (+0.41%)
S&P 500   3,971.35 (+0.01%)
DOW   32,375.05 (+0.43%)
QQQ   309.27 (-0.52%)
AAPL   159.21 (-0.65%)
MSFT   277.22 (-1.19%)
META   202.87 (-1.52%)
GOOGL   102.75 (-2.55%)
AMZN   97.54 (-0.60%)
TSLA   194.71 (+2.26%)
NVDA   266.33 (-0.55%)
NIO   8.88 (-2.09%)
BABA   85.58 (-1.52%)
AMD   96.22 (-1.77%)
T   18.88 (+1.45%)
F   11.50 (-0.09%)
MU   59.55 (-2.63%)
CGC   1.88 (-1.32%)
GE   93.08 (+1.87%)
DIS   94.63 (+0.58%)
AMC   4.32 (-3.36%)
PYPL   73.77 (-0.15%)
PFE   40.34 (-0.12%)
NFLX   329.75 (+0.41%)
S&P 500   3,971.35 (+0.01%)
DOW   32,375.05 (+0.43%)
QQQ   309.27 (-0.52%)
AAPL   159.21 (-0.65%)
MSFT   277.22 (-1.19%)
META   202.87 (-1.52%)
GOOGL   102.75 (-2.55%)
AMZN   97.54 (-0.60%)
TSLA   194.71 (+2.26%)
NVDA   266.33 (-0.55%)
NIO   8.88 (-2.09%)
BABA   85.58 (-1.52%)
AMD   96.22 (-1.77%)
T   18.88 (+1.45%)
F   11.50 (-0.09%)
MU   59.55 (-2.63%)
CGC   1.88 (-1.32%)
GE   93.08 (+1.87%)
DIS   94.63 (+0.58%)
AMC   4.32 (-3.36%)
PYPL   73.77 (-0.15%)
PFE   40.34 (-0.12%)
NFLX   329.75 (+0.41%)
S&P 500   3,971.35 (+0.01%)
DOW   32,375.05 (+0.43%)
QQQ   309.27 (-0.52%)
AAPL   159.21 (-0.65%)
MSFT   277.22 (-1.19%)
META   202.87 (-1.52%)
GOOGL   102.75 (-2.55%)
AMZN   97.54 (-0.60%)
TSLA   194.71 (+2.26%)
NVDA   266.33 (-0.55%)
NIO   8.88 (-2.09%)
BABA   85.58 (-1.52%)
AMD   96.22 (-1.77%)
T   18.88 (+1.45%)
F   11.50 (-0.09%)
MU   59.55 (-2.63%)
CGC   1.88 (-1.32%)
GE   93.08 (+1.87%)
DIS   94.63 (+0.58%)
AMC   4.32 (-3.36%)
PYPL   73.77 (-0.15%)
PFE   40.34 (-0.12%)
NFLX   329.75 (+0.41%)
OTCMKTS:ACKAY

Arçelik Anonim Sirketi - ACKAY Stock Forecast, Price & News

$33.40
0.00 (0.00%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$33.40
$33.40
50-Day Range
$25.97
$33.40
52-Week Range
$17.46
$33.40
Volume
9 shs
Average Volume
1,280 shs
Market Capitalization
N/A
P/E Ratio
7.47
Dividend Yield
5.22%
Price Target
$92.00

Arçelik Anonim Sirketi MarketRank™ Forecast

Analyst Rating
Hold
1.67 Rating Score
Upside/​Downside
175.4% Upside
$92.00 Price Target
Short Interest
Bearish
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.82 out of 5 stars


ACKAY stock logo

About Arçelik Anonim Sirketi (OTCMKTS:ACKAY) Stock

Arçelik AS engages in the production, distribution, sales and marketing of consumer durable goods, and consumer electronics. It operates through the following segments: White Goods, Consumer Electronics and Other. The White Goods segment comprises of washing machines, dryers, dish washers, refrigerators, ovens, and cookers. The Consumer Electronics segment includes television, computers, cash registers, and other electronic devices. The Other segment includes home appliances, furniture, and kitchen gadgets. The company was founded by Vehbi Koc on January 21, 1955 and is headquartered in Beyoglu,Turkey.

Receive ACKAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arçelik Anonim Sirketi and its competitors with MarketBeat's FREE daily newsletter.

ACKAY Stock News Headlines

Galata Wind Enerji Anonim Sirket (GWIND)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Arçelik Anonim Sirketi (ARCLK.IS)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
ARÇELİK PUBLISHES ITS 14TH SUSTAINABILITY REPORT
Arçelik Anonim Sirketi (ACKAY)
Arcelik Anonim Sirketi (ACKAF)
Arçelik Anonim Sirketi (RCAA.SG)
Arçelik A.Ş Files IP Lawsuit Against LG
See More Headlines
Receive ACKAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arçelik Anonim Sirketi and its competitors with MarketBeat's FREE daily newsletter.

ACKAY Company Calendar

Ex-Dividend for 4/6 Dividend
3/20/2023
Today
3/27/2023
Dividend Payable
4/06/2023

Industry, Sector and Symbol

Industry
Consumer Electronics
Sub-Industry
N/A
Current Symbol
OTCMKTS:ACKAY
CIK
N/A
Fax
N/A
Employees
39,487
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$92.00
High Stock Price Forecast
$92.00
Low Stock Price Forecast
$92.00
Forecasted Upside/Downside
+175.4%
Consensus Rating
Hold
Rating Score (0-4)
1.67
Research Coverage
3 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Hakan Hamdi Bulgurlu
    CEO, GM & Non-Independent Executive Director
  • Özkan Çimen
    Director-Finance & Enterprise Risk
  • Naci Yekta Caymaz
    Director-Information Technologies
  • Nihat Bayiz
    Director-Research & Development
  • Umut Nazif Çelik
    Director-Legal & Compliance













ACKAY Stock - Frequently Asked Questions

Should I buy or sell Arçelik Anonim Sirketi stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Arçelik Anonim Sirketi in the last twelve months. There are currently 1 sell rating and 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ACKAY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ACKAY, but not buy additional shares or sell existing shares.
View ACKAY analyst ratings
or view top-rated stocks.

What is Arçelik Anonim Sirketi's stock price forecast for 2023?

3 equities research analysts have issued 12 month target prices for Arçelik Anonim Sirketi's shares. Their ACKAY share price forecasts range from $92.00 to $92.00. On average, they anticipate the company's stock price to reach $92.00 in the next year. This suggests a possible upside of 175.4% from the stock's current price.
View analysts price targets for ACKAY
or view top-rated stocks among Wall Street analysts.

How have ACKAY shares performed in 2023?

Arçelik Anonim Sirketi's stock was trading at $27.34 on January 1st, 2023. Since then, ACKAY stock has increased by 22.2% and is now trading at $33.40.
View the best growth stocks for 2023 here
.

How often does Arçelik Anonim Sirketi pay dividends? What is the dividend yield for Arçelik Anonim Sirketi?

Arçelik Anonim Sirketi declared a dividend on Friday, March 17th. Stockholders of record on Tuesday, March 21st will be given a dividend of $0.3072 per share on Thursday, April 6th. This represents a yield of 1.03%. The ex-dividend date of this dividend is Monday, March 20th.
Read our dividend analysis for ACKAY
.

Is Arçelik Anonim Sirketi a good dividend stock?

Arçelik Anonim Sirketi (OTCMKTS:ACKAY) pays an annual dividend of $1.74 per share and currently has a dividend yield of 2.51%. The dividend payout ratio is 39.02%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for ACKAY.

What is Arçelik Anonim Sirketi's stock symbol?

Arçelik Anonim Sirketi trades on the OTCMKTS under the ticker symbol "ACKAY."

How do I buy shares of Arçelik Anonim Sirketi?

Shares of ACKAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Arçelik Anonim Sirketi's stock price today?

One share of ACKAY stock can currently be purchased for approximately $33.40.

How many employees does Arçelik Anonim Sirketi have?

The company employs 39,487 workers across the globe.

How can I contact Arçelik Anonim Sirketi?

The official website for the company is www.arcelikas.com. The company can be reached via phone at 902123143434.

This page (OTCMKTS:ACKAY) was last updated on 3/27/2023 by MarketBeat.com Staff